AG
FMI

Advisor Group’s Foundation Medicine, Inc. FMI Stock Holding History

Advisor Group’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-402
Closed -$55K – 5372
2018
Q2 		$55K Sell
402
-1,073
-73% -$97.5K ﹤0.01% 3033
2018
Q1 		$116K Buy
1,475
+304
+26% +$22.4K ﹤0.01% 2450
2017
Q4 		$80K Buy
1,171
+296
+34% +$15.3K ﹤0.01% 2749
2017
Q3 		$35K Sell
875
-400
-31% -$15.4K ﹤0.01% 3209
2017
Q2 		$51K Sell
1,275
-100
-7% -$3.66K ﹤0.01% 2852
2017
Q1 		$44K Buy
1,375
+498
+57% +$12.4K ﹤0.01% 2819
2016
Q4 		$16K Sell
877
-37,859
-98% -$816K ﹤0.01% 3380
2016
Q3 		$904K Sell
38,736
-599
-2% -$13.6K 0.02% 675
2016
Q2 		$733K Buy
+39,335
New +$711K 0.02% 732

Advisor Group's FMI Position: Q3 2018 in Review

Advisor Group sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 402 shares — an estimated $55K sold.

Advisor Group first reported a position in FMI in Q2 2016 and held it in 9 quarters. The position peaked at $904K in Q3 2016. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Advisor Group reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Advisor Group sold 402 Foundation Medicine, Inc. shares in Q3 2018, an estimated $55K.
  • Advisor Group first reported a position in Foundation Medicine, Inc. in Q2 2016 and held it in 9 quarters.
  • Advisor Group's Foundation Medicine, Inc. position peaked at $904K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Advisor Group's 13F filing for Q3 2018, filed 14 Nov 2018.